 Vancomycin
"Vancomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
| Descriptor ID |
D014640
|
| MeSH Number(s) |
D09.400.420.925 D12.644.233.925
|
| Concept/Terms |
Vancocin- Vancocin
- Vancocin HCl
- Vancomycin Lilly
- Vancocine
|
Below are MeSH descriptors whose meaning is more general than "Vancomycin".
Below are MeSH descriptors whose meaning is more specific than "Vancomycin".
This graph shows the total number of publications written about "Vancomycin" by people in this website by year, and whether "Vancomycin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 | | 2004 | 0 | 1 | 1 | | 2006 | 1 | 0 | 1 | | 2007 | 2 | 0 | 2 | | 2009 | 2 | 2 | 4 | | 2010 | 1 | 0 | 1 | | 2011 | 0 | 1 | 1 | | 2013 | 3 | 1 | 4 | | 2014 | 1 | 1 | 2 | | 2015 | 1 | 0 | 1 | | 2016 | 1 | 2 | 3 | | 2017 | 1 | 0 | 1 | | 2018 | 3 | 2 | 5 | | 2019 | 4 | 4 | 8 | | 2020 | 1 | 3 | 4 | | 2021 | 1 | 3 | 4 | | 2022 | 0 | 4 | 4 | | 2023 | 1 | 8 | 9 | | 2024 | 1 | 1 | 2 | | 2025 | 2 | 3 | 5 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vancomycin" by people in Profiles.
-
O'Toole RV, O'Hara NN, Carlini AR, Schrank GM, Chung S, Gary JL, Obremskey W, Matuszewski PE, Teague D, Natoli RM, Gitajn IL, Weaver MJ, Renninger CH, Levack AE, Degani Y, Collins SC, Weston-Farber E, Howe AL, Thompson RE, Castillo RC, Karunakar MA, Blum L, Harmer L, Hsu JR, Kempton LB, Phelps KD, Seymour RB, Sims SH, Acharya MS, Callahan H, Chavez-Araujo LM, Churchill C, Gambuzza MP, Haim KR, Ishman E, Kendall JS, Mullis ND, Young C, Pilson HT, Carroll EA, Goodman JB, Holden MB, Jones AL, Moon C, Lin CA, Marecek GS, Moffitt GB, Conlan T, George AV, Fisher LA, Mullin DS, Recendez CL, Aneja A, Brameier DT, Heng M, Ly TV, Stenquist DS, Suneja N, Wignakumar T, Borgida JS, Policicchio TJ, Hanson GR, Alese OM, Ricci WM, Behrens SB, Dvorzhinskiy A, Bilodeau RE, Klinger CE, Mullis BH, Jang Y, Lopas LA, McKinley TO, O'Neill DC, Szatkowski JP, Virkus WW, Hill LC, Gaski G, Hymes RA, Ahn J, Goch AM, Holzman M, Malekzadeh AS, Schulman JE, Rivera JC, Krause PC, Bridgman C, Cohen J, Eikani C, Chavez M, Kudulis M, Warner SJ, Achor TS, Choo A, Eastman JG, Kellam PJ, Boutte SJ, Guevara KD, Reid KR, Vallier HA, Tucci AV, Davis JM, Bell AC, Bonyun ME, Healey K, Li V, McKibben NS, Nascone J, Okhuereigbe D, Sciadini MF, Slobogean G, Zingas N, Kovvur M, Lawrence JE, Phipps H, Rudnicki J, Turner KE, Hayda R, Evans AR, Quinnan S, Benitez A, Rehman S, Soderquist MC, Townsend CB, Caroom C, Collins AC, Okwumabua E, Shaikh HS, Spitler CA, Agarwal A, Johnson MD, Haller JM, Marchand LS, Alfonso NA, Gorman MA, Charlton WM, Scott BR, Kraus KM, Meredith SJ, Talwar S, Bergin PF, Jha AJ, McGee S, Nehete PV, Pryor TA, Spears I, Chen AT, Kelley B, Nez NR, Ertl WJ, Hull BR, Blumenthal S, Patterson JT, Flynn C, Ross RC, Agarwal A, Weiss DB, Hadeed MM, Yarboro SR, Daoud T, McVey ED, Whiting PS, Domes C, Goodspeed DC, Kuhn GR, Boyce R, Libos A, Mitchell PM, Moreno-Diaz AF, Ponce RB, Stinner DJ, Tatman LM, Velasco-Castro J, Trochez K, Satpathy J, Zuelzer DA, Potter BK. Intrawound Tobramycin Plus Vancomycin to Prevent Surgical Site Infection in Tibial Fractures: The TOBRA Randomized Clinical Trial. JAMA. 2026 May 12; 335(18):1586-1595.
-
Stoner AK, Pezzanite LM, Dow SW, Alfonso NA, McGilvray KC. An In Vitro Assessment of a Biopolymer-Based Medical Foam for Enhanced Antifibrinolytic and Infection Prophylaxis for Acute Wound Management. ACS Appl Bio Mater. 2025 Dec 15; 8(12):10878-10889.
-
Krsak M, Klimpl D, Mueller SW, Morrisette T, Grimshaw AA, Chastain D, Steuber T, Sah R, Henao-Martinez AF, Molina KC. Oritavancin for Treatment of Osteomyelitis: A Systematic Review and Meta-Analysis of Observational Studies. Pharmacotherapy. 2025 11; 45(11):754-763.
-
Steinke JM, Gist KM, Askenazi D, Ogden RK, Shin S, Sutherland S, Yonekawa K, Mahon AR, Fadrowski J, Misurac J, Semanik M, Goldstein SL. A multi-center collaborative highlights the differences in nephrotoxic medication exposure and associated AKI in pediatric bone marrow transplant, oncology, and pulmonary service lines. Pediatr Nephrol. 2026 Mar; 41(3):865-872.
-
Sajid MI, Grayson W, John MP, Taylor S, Lauck BJ, Zaidi Z, Savage A, Griffin N, Awad M, Chen AT, Hwang J, Alfonso N, Mir HR. Efficacy of Topical Antibiotic Powder Application in the Emergency Department on Reducing Deep Fracture-Related Infection in Type III Open Lower Extremity Fractures: A Multicenter Study. J Am Acad Orthop Surg. 2025 Dec 15; 33(24):e1489-e1496.
-
Krsak M, Morrisette T, Damioli L, Flues B, Liu EW, Zhou AY, Msdi AS, McLeod C, Akundi S, Redell M, Molina KC. Can Oritavancin Be Used for Treatment and/or Suppressive Antimicrobial Therapy of Bone and Joint Infections Caused by Vancomycin-resistant Enterococcus faecium ? Clin Orthop Relat Res. 2025 Mar 14; 483(7):1225-1233.
-
Hart CM, Kelley BV, Mamouei Z, Turkmani A, Ralston M, Arnold M, Bernthal NM, Sassoon AA. Antibiotic calcium sulphate beads lower the bacterial burden and prevent infection in a mouse model of periprosthetic joint infection. Bone Joint J. 2024 Jun 01; 106-B(6):632-638.
-
Pesante BD, Parry JA. The Effect of Vancomycin and Tobramycin Local Antibiotic Powder on Surgical Site Infections After Open Treatment of Fracture: A Retrospective Propensity-Matched Analysis. J Orthop Trauma. 2024 04 01; 38(4):177-182.
-
Ricciuto A, Liu K, El-Matary W, Amin M, Amir AZ, Aumar M, Auth M, Di Guglielmo MD, Druve Tavares Fagundes E, Rodrigues Ferreira A, Furuya KN, Gupta N, Guthery S, Horslen SP, Jensen K, Kamath BM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Mack C, Martinez M, Montano-Loza A, Ovchinsky N, Papadopoulou A, Perito ER, Sathya P, Schwarz KB, Shah U, Shteyer E, Soufi N, Stevens JP, Taylor A, Tessier ME, Valentino P, Woynarowski M, Deneau M. Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium. Aliment Pharmacol Ther. 2024 05; 59(10):1236-1247.
-
Tegethoff JI, Teitelbaum I, Kiser TH. Rapid and Effective Treatment of Peritonitis in Peritoneal Dialysis Patients with Intravenous Dalbavancin. Am J Case Rep. 2024 Jan 26; 25:e942755.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|